Comparison of a 1.25 mg/ml intralesional triamcinolone acetonide with combination of a 1.25 mg/ml intralesional triamcinolone acetonide and comedone extraction in healing of inflammatory acnes in moderate-to-severe adult acne: a randomized, split-face controlled trial
Phase 3
- Conditions
- moderate to severe acneInflammatory acne, intralesional triamcinolone acetatonide, intralesional corticosteroid
- Registration Number
- TCTR20210924008
- Lead Sponsor
- Dermatology unit, department of internal medicine, Chulalongkorn university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
1. moderate-to-severe acne patients with equally distributed acne papules on both sides of one's face (different papules no more than 5 papules)
2. no prior history of procedure on the papules such as chemical peeling, laser
3. The volunteers have their own cell phones in which the camera's pixel is more than 7 million pixel
Exclusion Criteria
1. allergic to triamcinolone acetonide
2. can't tolerate intralesional procedure and comedone extraction
3. psychiatric problem
4. willing to do other procedures (such as chemical peeling, laser) during the research period (6 month)
5. history of prior keloid and hypertrophic scar
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method healing of inflammatory papule 7 days A numbers of day after the procedures
- Secondary Outcome Measures
Name Time Method post acne erythema 1, 3, 6 month IQR